The Advisory Board Co. (ABCO) CEO Sells $241,395.00 in Stock
The Advisory Board Co. (NASDAQ:ABCO) CEO Robert W. Musslewhite sold 5,500 shares of the firm’s stock in a transaction on Monday, October 10th. The shares were sold at an average price of $43.89, for a total value of $241,395.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
The Advisory Board Co. (NASDAQ:ABCO) traded up 1.72% on Wednesday, reaching $43.76. The company’s stock had a trading volume of 243,435 shares. The Advisory Board Co. has a one year low of $18.87 and a one year high of $54.83. The stock’s market cap is $1.76 billion. The stock has a 50-day moving average of $43.10 and a 200-day moving average of $37.20.
The Advisory Board (NASDAQ:ABCO) last announced its quarterly earnings results on Wednesday, July 27th. The company reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.13. The firm had revenue of $198.40 million for the quarter, compared to the consensus estimate of $196.49 million. The Advisory Board had a positive return on equity of 11.59% and a negative net margin of 10.21%. The company’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.40 earnings per share. On average, analysts predict that The Advisory Board Co. will post $1.86 EPS for the current fiscal year.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/12/the-advisory-board-co-abco-ceo-sells-241395-00-in-stock.html
Several equities analysts have weighed in on the company. Barclays PLC raised their price objective on The Advisory Board from $41.00 to $44.00 and gave the company an “overweight” rating in a research note on Thursday, July 28th. Cantor Fitzgerald reiterated a “hold” rating and set a $37.00 target price on shares of The Advisory Board in a research note on Thursday, July 28th. Zacks Investment Research cut The Advisory Board from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 12th. Oppenheimer Holdings Inc. set a $45.00 target price on The Advisory Board and gave the stock a “buy” rating in a research note on Thursday, July 28th. Finally, Credit Suisse Group AG assumed coverage on The Advisory Board in a research note on Monday, June 20th. They set an “outperform” rating and a $40.00 target price on the stock. Five equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. The Advisory Board currently has a consensus rating of “Buy” and an average price target of $44.07.
Several hedge funds and other institutional investors have recently made changes to their positions in ABCO. Raymond James & Associates increased its position in shares of The Advisory Board by 0.4% in the second quarter. Raymond James & Associates now owns 7,067 shares of the company’s stock worth $250,000 after buying an additional 28 shares during the last quarter. BlackRock Advisors LLC increased its position in shares of The Advisory Board by 0.4% in the second quarter. BlackRock Advisors LLC now owns 19,655 shares of the company’s stock worth $696,000 after buying an additional 73 shares during the last quarter. Rhumbline Advisers increased its position in shares of The Advisory Board by 0.6% in the second quarter. Rhumbline Advisers now owns 50,804 shares of the company’s stock worth $1,798,000 after buying an additional 292 shares during the last quarter. BlackRock Inc. increased its position in shares of The Advisory Board by 16.2% in the second quarter. BlackRock Inc. now owns 3,263 shares of the company’s stock worth $116,000 after buying an additional 455 shares during the last quarter. Finally, Teacher Retirement System of Texas increased its position in shares of The Advisory Board by 13.8% in the second quarter. Teacher Retirement System of Texas now owns 5,856 shares of the company’s stock worth $207,000 after buying an additional 708 shares during the last quarter.
The Advisory Board Company Profile
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.
Receive News & Ratings for The Advisory Board Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Co. and related companies with MarketBeat.com's FREE daily email newsletter.